| Income Statement | 2025-09-30 | 2025-06-30 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|
| Net income (loss) | 2,355 | 164 | 3,236 | -2,203 |
| Earnings per share, basic | 0.03 | 0 | 0.04 | -0.03 |
| Earnings per share, diluted | 0.03 | 0 | 0.03 | -0.03 |
| Weighted average number of shares outstanding, basic | 79,281,685 | 78,663,884 | 73,549,745 | 73,308,281 |
| Weighted average number of shares outstanding, diluted | 80,814,564 | 81,271,610 | 81,217,068 | 73,308,281 |
Protalix BioTherapeutics, Inc. (PLX)
Protalix BioTherapeutics, Inc. (PLX)